Arkadios Wealth Advisors Mustang Bio, Inc. Transaction History

Arkadios Wealth Advisors

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 28, 2021	SELL	$2.7 - $3.81 $27,000 - $38,100	-10,000 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$3.02 - $5.16 $54,360 - $92,880	-18,000 Reduced 64.29%	10,000 $33,000
Q4 2020 Feb 09, 2021	BUY	$2.66 - $4.18 $74,480 - $117,039	28,000 New	28,000 $105,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Arkadios Wealth Advisors, based on Form 13F filings with the SEC.

Stay updated on Arkadios Wealth Advisors with notifications on news.